← Back to Search

Intervention for Multiple Myeloma

N/A

Waitlist Available

Led By Edward Stadtmauer, MD

Research Sponsored by Abramson Cancer Center of the University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

Study Summary

This trial will develop and evaluate a financial support program for cancer patients to reduce barriers to treatment access. #CancerTreatment

Eligible Conditions

Multiple Myeloma

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COmprehensive Score for Financial Toxicity (COST)

Secondary outcome measures

Functional Assessment of Cancer Therapy (FACT-G)

Patient Satisfaction Questionnaire Short-Form [PSQ-18]

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Patients randomized to the intervention arm will be enrolled in a four-month coordinated financial navigation program. This program will take a more proactive, coordinated, and systematic approach and includes concrete action plans, and frequent and standardized follow-ups. All patients randomized to the intervention arm will meet with the nurse navigator (NN) for an intake. The NN will introduce navigation services and navigator's NN role and describe the financial navigation program (e.g., goals and expectations of the financial advocacy and social work programs). Next, the navigator will elicit from the patient their potential and current barriers to completing the diagnostic test or treatment. The navigator will then perform proactive outreach to these resources and coordinate an action plan with the patient.

Group II: Usual CareActive Control1 Intervention

Patients are connected to financial advocacy and social work on an ad hoc basis, rather than systematically. We hypothesize that many patients who would qualify and benefit from these services are not using them or are being referred late in their treatment course, which is contributing to their financial hardship and adversely affecting their healthcare.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor

359 Previous Clinical Trials

104,941 Total Patients Enrolled

7 Trials studying Multiple Myeloma

157 Patients Enrolled for Multiple Myeloma

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

145,541 Total Patients Enrolled

8 Trials studying Multiple Myeloma

232 Patients Enrolled for Multiple Myeloma

Edward Stadtmauer, MDPrincipal InvestigatorPenn Medicine

5 Previous Clinical Trials

79 Total Patients Enrolled

4 Trials studying Multiple Myeloma

32 Patients Enrolled for Multiple Myeloma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining in this research project?

"The information published on clinicaltrials.gov verifies that this medical research is currently accepting participants. It was initially posted on the 4th March 2022 and subsequently updated on 24th October of the same year. This study requires 74 people to join from a single location."

Answered by AI

How many individuals have been granted access to this research project?

"Affirmative. The records on clinicaltrials.gov demonstrate that this research proposal was first released on April 3rd 2022, and is currently looking for volunteers. 74 individuals must be enrolled across one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma

2022. "Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05448196.